Curaleaf Holdings (CURLF) Interest Coverage Ratio (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Interest Coverage Ratio of 0.03 for Q4 2025, down 99.8% year-on-year from 17.54 in Q4 2024, and down 99.8% on a QoQ basis from 17.54 in Q4 2024.
Curaleaf Holdings (CURLF) Interest Coverage Ratio (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Interest Coverage Ratio for 7 consecutive years, with 0.03 the latest figure, recorded in Q4 2025.
- Quarterly Interest Coverage Ratio fell 99.8% year-over-year to 0.03 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.09 (down 96.45% YoY) and the FY2025 annual result came in at 0.04, down 26.42% from the prior year.
- Interest Coverage Ratio fell to 0.03 in Q4 2025 per CURLF's latest filing, from 17.54 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for CURLF reached as high as 108.73 in Q1 2021 and fell as low as 0.0 in Q4 2023.
- A 5-year average of 21.68 and a median of 6.68 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio slumped 100.0% — and 2024, when it jumped 9469673.99%.
- Year by year, Interest Coverage Ratio stood at 1.29 in 2021, then surged by 260.0% to 4.65 in 2022, then sank by 100.0% to 0.0 in 2023, then soared by 9469673.99% to 17.54 in 2024, then tumbled by 99.8% to 0.03 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.03, 17.54, and 1.84 for Q4 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.03 |
| Dec 31, 2024 | 17.54 |
| Sep 30, 2024 | 1.84 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 17.05 |
| Dec 31, 2022 | 4.65 |
| Sep 30, 2022 | 8.71 |
| Sep 30, 2021 | 1.29 |
| Jun 30, 2021 | 56.96 |
| Mar 31, 2021 | 108.73 |
| Dec 31, 2020 | 1.17 |
| Sep 30, 2020 | 1.62 |
| Jun 30, 2020 | 2.22 |
| Mar 31, 2020 | 0.60 |
| Dec 31, 2019 | -4.00 |